Search results
Results from the Health.Zone Content Network
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), the virus that causes coronavirus disease 2019 ( COVID‑19 ). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing ...
of people receiving a COVID-19 vaccine for the first time experienced this side effect. Guillain-Barré syndrome (GBS). GBS is a rare side effect that can cause the immune system to attack healthy ...
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries.
Andrews N, et al. (2021). Effectiveness of COVID-19 vaccines against the Omicron ... Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: ...
The four types of COVID-19 vaccines being used around the world are: messenger RNA (mRNA) vaccines. viral vector vaccines. protein subunit vaccines. whole virus vaccines. The table below provides ...
2 min read. Oct. 13, 2023 – About 7 million people in the U.S. have gotten the new COVID-19 vaccine as the nation heads into what health officials now consider cold, flu, and COVID season. The ...
The 54% vaccine effectiveness is based on a study from September through earlier this month of 9,222 COVID tests in the Community Access to Testing SARS-CoV-2 pharmacy testing program. Both CVS ...